Concord Biotech Limited has informed the Exchange about General Updates-Disclosure under Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech has submitted a routine regulatory filing to NSE and BSE disclosing its updated list of Key Managerial Personnel (KMPs) who are authorized to determine the materiality of any event or information and to make disclosures to the stock exchanges. The revised KMP list includes four members: Mr. Sudhir Vaid (Chairman and Managing Director), Mr. Ankur Vaid (Joint Managing Director and CEO), Mr. Lalit Sethi (Chief Financial Officer), and Ms. Hina Patel (Company Secretary and Compliance Officer). The contact details provided are the company's Ahmedabad office at Mondeal Heights, S.G. Highway. The filing was signed digitally by Ms. Hina Patel on June 2, 2025.
This is a routine administrative compliance update with no material impact on the company's business, financials, or share price. It simply restates who within the company is authorized to handle stock exchange disclosures.